Research graph
References from From black box warning to wake-up call: menopausal hormone therapy prescribing patterns at a large academic medical center. Local targets link to admitted publications; unresolved targets remain external evidence.
Menopause and MHT in 2024: addressing the key controversies – an International Menopause Society White Paper
10.1080/13697137.2024.2394950 · 2024 · External reference
Management of menopausal symptoms: a review
10.1001/jama.2022.24140 · 2023 · External reference
Posner JG. The normal menopause transition
10.1016/j.maturitas.2008.09.005 · 2008 · External reference
Postmenopausal estrogen therapy and cardiovascular disease: ten-year follow-up from the Nurses’ Health Study
10.1056/nejm199109123251102 · 1991 · External reference
Menopausal hormone therapy use among postmenopausal women
10.1001/jamahealthforum.2024.3128 · 2024 · External reference
The controversial history of hormone replacement therapy
10.3390/medicina55090602 · 2019 · External reference
Promotion and prescribing of hormone therapy after report of harm by the Women’s Health Initiative
10.1001/jama.292.16.1983 · 2004 · External reference
Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women’s Health Initiative randomized controlled trial
10.1001/jama.288.3.321 · 2002 · External reference
Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women’s Health Initiative randomized controlled trial
10.1001/jama.288.3.321 · 2002 · External reference
National use of postmenopausal hormone therapy: annual trends and response to recent evidence
10.1001/jama.291.1.47 · 2004 · External reference
Evolution of postmenopausal hormone therapy between 2002 and 2009
10.1097/gme.0b013e31823a3e5d · 2012 · External reference
Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women’s Health Initiative randomized controlled trial
10.1001/jama.291.14.1701 · 2004 · External reference
Persistent gaps in menopause care: current recommendations of the POESIT group
10.1016/j.maturitas.2025.108607 · 2025 · External reference
Menopause management—getting clinical care back on track
10.1056/nejmp1514242 · 2016 · External reference
Menopausal hormone therapy and long-term all-cause and cause-specific mortality
10.1001/jama.2017.11217 · 2017 · External reference
Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause
10.1001/jama.297.13.1465 · 2007 · External reference
Rethinking menopausal hormone therapy: for whom, what, when, and how long?
10.1161/circulationaha.122.061559 · 2023 · External reference
The 2022 hormone therapy position statement of The North American Menopause Society
10.1097/gme.0000000000002028 · 2022 · External reference
Treatment of symptoms of the menopause: an Endocrine Society clinical practice guideline
10.1210/jc.2015-2236 · 2015 · External reference
Persistent gap in menopause care 20 years after the WHI: a population-based study of menopause-related symptoms and their management
10.1016/j.maturitas.2022.08.003 · 2022 · External reference
Effective prevention of recurrent UTIs with vaginal estrogen: pearls for a urological approach to genitourinary syndrome of menopause
10.1016/j.urology.2020.05.058 · 2021 · External reference
Efficacy of vaginal estrogen for recurrent urinary tract infection prevention in hypoestrogenic women
10.1016/j.ajog.2023.05.002 · 2023 · External reference
Updated labeling for menopausal hormone therapy
10.1001/jama.2025.22259 · 2026 · External reference
